Journal article icon

Journal article

Effective Performance of the 2022 American College of Rheumatology/ EULAR Classification Criteria for Antineutrophil Cytoplasmic Antibody–Associated Vasculitis in Pediatric Patients: An ARChiVe Study

Abstract:
Objective: To assess the 2022 American College of Rheumatology (ACR)/EULAR classification criteria for antineutrophil cytoplasmic antibody–associated vasculitis (AAV) in children with chronic small‐to‐medium vessel vasculitis. Methods: A cohort of 574 patients, identified by physician's diagnosis (MD‐diagnosis) in A Registry of Childhood Vasculitis, was classified by computation of registry data as having granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), or eosinophilic GPA after applying (1) ACR/EULAR AAV criteria and (2) pediatric‐adapted European Medicines Agency (Ped‐EMA) classification algorithm (incorporating Ankara GPA criteria). Venn diagrams compared the resulting GPA and MPA cohorts with MD‐diagnosis. Sensitivity and specificity of criteria for GPA were evaluated against MD‐diagnosis. Fisher exact test evaluated differences in the frequencies of individual clinical features in GPA versus MPA. Results: Comparing ACR/EULAR criteria against the Ped‐EMA algorithm for classifying AAV, more patients were classified as GPA or MPA (n = 396 vs 360, respectively), fewer had GPA (n = 261 vs 288, respectively), more had MPA (n = 135 vs 72, respectively), and fewer GPA cases coclassified as MPA (12% vs 28%, respectively); there were more differences between GPA and MPA in Pediatric Vasculitis Activity Score–defined clinical features (n = 14 vs 10, respectively). When classifying GPA by ACR/EULAR or Ankara criteria, sensitivity (74.5% vs 72.1%, respectively) was comparable, and specificity for ACR/EULAR criteria (93.9% vs 79.9%, respectively) was improved. Conclusion: The 2022 ACR/EULAR classification criteria for AAV perform at least as well as previous pediatric criteria and provide categorical MPA criteria where none existed previously; the criteria for GPA and MPA now specifically differentiate each other, with more differences between them in the frequencies of clinical features. Our findings support the preferential use of ACR/EULAR over Ankara criteria for GPA in pediatrics. image
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1002/art.70172

Authors

More by this author
Role:
Author
ORCID:
0000-0003-1840-9210
More by this author
Role:
Author
ORCID:
0009-0000-8086-3604
More by this author
Role:
Author
ORCID:
0009-0001-6192-769X


More from this funder
Funder identifier:
https://ror.org/01gavpb45
Grant:
259696
More from this funder
Funder identifier:
https://ror.org/03f9wqe45


Publisher:
Wiley
Journal:
Arthritis & Rheumatology More from this journal
Article number:
art.70172
Publication date:
2026-05-05
Acceptance date:
2026-03-12
DOI:
EISSN:
2326-5205
ISSN:
2326-5191


Language:
English
Keywords:
Pubs id:
2405152
Local pid:
pubs:2405152
Source identifiers:
4016477
Deposit date:
2026-05-06
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP